Keyphrases
United States
100%
Cost-effectiveness
100%
Risk Level
100%
Statins
100%
Simvastatin
100%
Vascular Risk
100%
Major Vascular Injury
60%
Statin Therapy
40%
Randomized Controlled Trial
40%
Trial Data
40%
Event Risk
40%
Vascular Events
40%
Medical Care
20%
Vascular Disease
20%
Heart Attack
20%
Revascularization
20%
Current Guidelines
20%
Clinical Practice Guidelines
20%
Disease Model
20%
Lifetime Risk
20%
Hospital Costs
20%
Estimated Cost
20%
Life-years Gained
20%
Vascular Death
20%
Net Savings
20%
Net Cost
20%
Vascular Disease Risk
20%
Wider Population
20%
Daily Cost
20%
Project Lifetime
20%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Statin (Protein)
100%
Simvastatin
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
40%
Statins therapy
40%
Vascular Disease
40%
Heart Infarction
20%
Practice Guideline
20%
Cerebrovascular Accident
20%
Clinical Guideline
20%
Heart Muscle Revascularization
20%
Disease Model
20%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Simvastatin
100%
Randomized Controlled Trial
40%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
40%
Vascular Disease
40%
Heart Infarction
20%
Cerebrovascular Accident
20%
Disease Model
20%